[Effect of sequential preparation with ethinyl estradiol sulfonate soft gelatin capsules and norethindrone acetate on carbohydrate metabolism].
An intravenous glucose tolerance test (i.v.GTT) was done before and after 6 months of using a sequential-type oral contraceptive in form of a weekly pill containing 0,6 mg ethinylestradiol-sulfonate (EES) soft gelatin capsules and 10 mg norethisterone acetate (NEA). 17 fertile, eumetabolic women are examined . There was no change neither average fasting blood glucose nor glucose assimilation after intake of ethinylestradiol. Basal as well as reactive insulin values increased by longer period of intake.
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D002214:Capsules; D004334:Drug Administration Schedule; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D005260:Female; D005780:Gelatin; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood*; D009640:Norethindrone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D000077563:Norethindrone Acetate; D014677:Pharmaceutical Vehicles
D001786:Blood Glucose; D002214:Capsules; D007328:Insulin; D014677:Pharmaceutical Vehicles; C025723:ethinyl estradiol sulfonate; D004997:Ethinyl Estradiol; D005780:Gelatin; D000077563:Norethindrone Acetate; D009640:Norethindrone
Einfluss des Sequenzpräparates mit Athinylöstradiolsulfonat-Weichgelatinekapseln und Noräthisteronazetat auf den Kohlenhydratstoffwechsel.